report-image

Breast Cancer Market Analysis by Therapy (Hormonal Therapy, Targeted Therapy, Surgery and radiation therapy, Biologic therapy), By Cancer Type (Hormone Receptor, HER2+), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others) and by Region: Global Forecast, 2024 - 2034

  • PUBLISHED ON
  • 2024-04-17
  • NO OF PAGES
  • 191
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Breast Cancer market is predicted to develop at a compound annual growth rate (CAGR) of 10% from 2024 to 2034, when it is projected to reach USD 73.21 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 31.2 Billion in 2024.

 

SOURCE: We Market Research

A malignant growth that starts in the breast tissue, usually in the lobules or milk ducts, is called breast cancer. It is the most prevalent type of cancer in women globally. Breast lumps, nipple discharge, changes in skin texture or shape, and breast soreness are some of the symptoms. Hormonal effects, genetics, and lifestyle decisions are risk factors. For successful therapy, early diagnosis through screenings like mammograms is essential. Treatment choices include surgery, radiation, chemotherapy, hormone treatment, and targeted therapy, depending on the kind and stage of the cancer. Survival rates have increased as a result of increased knowledge and study, highlighting the significance of routine checkups and self-examinations.

Research, therapy, and market dynamics are shaped by a number of factors that influence the breast cancer market. Targeted medicines and customized medicine are being made possible by ongoing advances in genetic and molecular research. A stronger focus on early detection via genetic testing and mammography screening programs is improving patient outcomes. The demand for cutting-edge therapies and diagnostic tools is being driven by rising incidence rates worldwide. Survival rates are rising as a result of the emergence of innovative therapeutics including immunotherapy and combination therapies. Strong patient advocacy initiatives, research funding, and supportive government regulations all help the breast cancer market expand and thrive, which eventually benefits both patients and healthcare systems.

 

Market Scope

Report Attributes

Description

Market Size in 2024

USD 31.2 Billion

Market Forecast in 2034

USD 73.21Billion

CAGR % 2024-2034

10%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2034

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Therapy, By Cancer Type, By Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Breast Cancer Industry: Dynamics & Restrains


 

Market opportunity:


 

We Market Research: Breast Cancer Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.


Breast Cancer Segmentation

Market- By Therapy Analysis

By Therapy, the Breast Cancer Market is Categories into Hormonal Therapy, Targeted Therapy, Surgery and radiation therapy, Biologic therapy. The Targeted Therapy is the segment accounts for the largest share of around 79% in 2024.


Personalized care, exact efficacy against certain molecular targets, less side effects, breakthroughs in biomarkers for patient selection, advantages of combination therapy, and continuous innovation are the driving forces behind targeted therapy in breast cancer. This strategy improves results by providing personalized, efficient cancer care.

The following segments are part of an in-depth analysis of the global Breast Cancer market:

Market Segments

 

By  Cancer Type

·         Hormone Receptor

·         HER2+

By  Distribution Channel

·         Retail Pharmacies

·         Hospital Pharmacies

·         Online Pharmacies

·         Others

 

Breast Cancer Industry: Regional Analysis

North America Market Forecast

North America dominate the Breast Cancer Market with the highest revenue generating market with share of more than 48%. The Breast Cancer market in North America thrives due to the high prevalence of breast cancer, advanced healthcare infrastructure, early adoption of novel therapies, robust research and development activities, favorable reimbursement policies, and increasing awareness among patients and healthcare providers.


Europe Market Statistics

Europe is second largest region in Breast Cancer market due to the growing incidence of breast cancer, emphasis on personalized medicine, supportive regulatory environment for drug approvals, strong investments in healthcare, presence of leading pharmaceutical companies, and collaborative research initiatives.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Breast Cancer market during the forecast period. In the Asia Pacific region, rising awareness about breast cancer screening, improving healthcare access in developing countries, increasing disposable income, expanding investments in healthcare infrastructure, emergence of local pharmaceutical industries, and government initiatives to tackle cancer.

Key Market Players

The Breast Cancer Market is dominated by a few large companies, such as

·         Merck & Co

·         AstraZeneca

·         Novartis AG

·         Eli Lilly and Company

·         GlaxoSmithKline

·         Sanofi

·         Pfizer Inc

·         Genentech

·         Mylan Laboratories

·         Other


1.      Global Breast Cancer Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Breast Cancer Market Scope and Market Estimation

1.2.1. Global Breast Cancer Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Breast Cancer Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Component of Global Breast Cancer Market

1.3.2. Technology of Global Breast Cancer Market

1.3.3. Distribution Channel  of Global Breast Cancer Market

1.3.4. Region of Global Breast Cancer Market

2.      Executive Summary

2.1.    Global Breast Cancer Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Breast Cancer Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Breast Cancer Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Breast Cancer Market Estimates & Forecast Trend Analysis, by THERAPY

4.1.    Global Breast Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by THERAPY, 2019 to 2034

4.1.1. Hormonal Therapy

4.1.2. Targeted Therapy

4.1.3. Surgery and radiation therapy

4.1.4. Biologic therapy

5.      Global Breast Cancer Market Estimates & Forecast Trend Analysis, by Cancer Type

5.1.    Global Breast Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by Cancer Type, 2019 to 2034

5.1.1. Hormone Receptor

5.1.2. HER2+

6.      Global Breast Cancer Market Estimates & Forecast Trend Analysis, by Distribution Channel

6.1.    Global Breast Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel , 2019 to 2034

6.1.1. Retail Pharmacies

6.1.2. Hospital Pharmacies

6.1.3. Online Pharmacies

6.1.4. Others

7.      Global Breast Cancer Market Estimates & Forecast Trend Analysis, by Region

7.1.    Global Breast Cancer Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

7.1.1. North America

7.1.2. Europe

7.1.3. Asia Pacific

7.1.4. Middle East & Africa

7.1.5. South America

8.      North America Breast Cancer Market: Estimates & Forecast Trend Analysis

8.1.    North America Breast Cancer Market Assessments & Key Findings

8.1.1. North America Breast Cancer Market Introduction

8.1.2. North America Breast Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

8.1.2.1.   By THERAPY

8.1.2.2.   By Cancer Type

8.1.2.3.   By Distribution Channel

8.1.2.4.   By Country

8.1.2.4.1.     The U.S.

8.1.2.4.2.     Canada

8.1.2.4.3.     Mexico

9.      Europe Breast Cancer Market: Estimates & Forecast Trend Analysis

9.1.    Europe Breast Cancer Market Assessments & Key Findings

9.1.1. Europe Breast Cancer Market Introduction

9.1.2. Europe Breast Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By THERAPY

9.1.2.2.   By Cancer Type

9.1.2.3.   By Distribution Channel

9.1.2.4.        By Country

9.1.2.4.1.     Germany

9.1.2.4.2.     U.K.

9.1.2.4.3.     France

9.1.2.4.4.     Italy

9.1.2.4.5.     Spain

9.1.2.4.6.     Russia

9.1.2.4.7.     Rest of Europe

10.  Asia Pacific Breast Cancer Market: Estimates & Forecast Trend Analysis

10.1.  Asia Pacific Market Assessments & Key Findings

10.1.1.   Asia Pacific Breast Cancer Market Introduction

10.1.2.   Asia Pacific Breast Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By THERAPY

10.1.2.2.    By Cancer Type

10.1.2.3.    By Distribution Channel

10.1.2.4.    By Country

10.1.2.4.1. China

10.1.2.4.2. Japan

10.1.2.4.3. India

10.1.2.4.4. Australia

10.1.2.4.5. South Korea

10.1.2.4.6. ASEAN

10.1.2.4.7. Rest of Asia Pacific

11.  Middle East & Africa Breast Cancer Market: Estimates & Forecast Trend Analysis

11.1.  Middle East & Africa Market Assessments & Key Findings

11.1.1.   Middle East & Africa Breast Cancer Market Introduction

11.1.2.   Middle East & Africa Breast Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By THERAPY

11.1.2.2.    By Cancer Type

11.1.2.3.    By Distribution Channel

11.1.2.4.    By Country

11.1.2.4.1. U.A.E.

11.1.2.4.2. Saudi Arabia

11.1.2.4.3. Egypt

11.1.2.4.4. South Africa

11.1.2.4.5. Rest of Middle East & Africa

12.  South America Breast Cancer Market: Estimates & Forecast Trend Analysis

12.1.  South America Market Assessments & Key Findings

12.1.1.   South America Breast Cancer Market Introduction

12.1.2.   South America Breast Cancer Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By THERAPY

12.1.2.2.    By Cancer Type

12.1.2.3.    By Distribution Channel

12.1.2.4.    By Country

12.1.2.4.1. Brazil

12.1.2.4.2. Argentina

12.1.2.4.3. Colombia

12.1.2.4.4. Rest of South America

13.  Competition Landscape

13.1.  Global Breast Cancer Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

13.2.  Global Breast Cancer Market Competition White Space Analysis, By Distribution Channel

13.3.  Global Breast Cancer Market Competition Heat Map Analysis, By Distribution Channel

13.4.  Global Breast Cancer Market Concentration & Company Market Shares (%) Analysis, 2022

14.  Company Profiles

14.1.                     Merck & Co.

14.1.1.   Company Overview & Key Stats

14.1.2.   Financial Performance & KPIs

14.1.3.   Product Portfolio

14.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

14.2.      AstraZeneca

14.3.      Novartis AG

14.4.      Eli Lilly and Company

14.5.      GlaxoSmithKline

14.6.      Sanofi

14.7.      Pfizer Inc

14.8.      Genentech

14.9.      Mylan Laboratories

14.10.  Others

15.  Research Methodology

15.1.  External Transportations / Databases

15.2.  Internal Proprietary Database

15.3.  Primary Research

15.4.  Secondary Research

15.5.  Assumptions

15.6.  Limitations

15.7.  Report FAQs

16.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.